FDA says asthma drug Xolair raises risk of heart, brain problems – Yahoo News


GlobalPost

FDA says asthma drug Xolair raises risk of heart, brain problems
Yahoo News
WASHINGTON (Reuters) – The asthma drug Xolair is associated with a higher risk of heart attack, mini-stroke, chest pain and blood clots in the lungs and veins, among other problems, though the extent of increased risk is unclear, the U.S. Food and Drug …
FDA warns of increased risks of asthma drug XolairAAP News (subscription)
FDA: Asthma Drug May Increase Risk of CV, Cerebrovascular EventsMonthly Prescribing Reference

all 13 news articles »

View full post on asthma – Google News

Teva finds positive results in advanced trials for asthma drug – Yahoo News


Globes

Teva finds positive results in advanced trials for asthma drug
Yahoo News
TEL AVIV (Reuters) – Teva Pharmaceutical Industries said a drug under development had positive results in reducing the frequency of clinical asthma exacerbations in two advanced trials in patients with moderate to severe asthma. Reslizumab, an …
Teva's Reslizumab Shows Reduction In Asthma Exacerbations In Clinical StudiesRTT News
Teva reports positive Phase III asthma drug resultsGlobes

all 5 news articles »

View full post on asthma – Google News

AstraZeneca builds pipeline with $232 million Synairgen asthma deal – Yahoo News

AstraZeneca builds pipeline with $232 million Synairgen asthma deal
Yahoo News
LONDON (Reuters) – AstraZeneca has struck a deal worth up to $232 million in milestone payments to acquire rights to a drug from Synairgen for treating respiratory tract viral infections in patients with severe asthma. Britain's second-biggest
AstraZeneca Licences Asthma Exacerbation Treatment From SynairgenLondon South East
AstraZeneca licenses rights to Synairgen asthma drugMSN Money
Synairgen shares soar on AstraZeneca asthma dealProactive Investors UK
Cambridge Network
all 7 news articles »

View full post on asthma – Google News